Rowland & CO Investment Counsel Bristol Myers Squibb CO Transaction History

Rowland & CO Investment Counsel

$486 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$65.71 - $74.53 $38,900 - $44,121	-592 Reduced 28.63%	1,476 $102,000
Q4 2022 Jan 04, 2023	SELL	$68.48 - $81.09 $6,368 - $7,541	-93 Reduced 4.3%	2,068 $0
Q3 2022 Oct 06, 2022	BUY	$0.13 - $76.84 $18 - $10,834	141 Added 6.98%	2,161 $153,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $6,172 - $6,798	-85 Reduced 4.04%	2,020 $155,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $355,846 - $426,691	-5,788 Reduced 73.33%	2,105 $153,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $278,339 - $324,478	5,190 Added 192.01%	7,893 $492,000
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $23,845 - $27,931	403 Added 17.52%	2,703 $159,000
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $63,493 - $71,411	-1,070 Reduced 31.75%	2,300 $145,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $31,987 - $36,248	554 Added 19.67%	3,370 $209,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $6,489 - $7,191	113 Added 4.18%	2,816 $169,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $6,194 - $7,242	-113 Reduced 4.01%	2,703 $158,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $14,012 - $20,363	-302 Reduced 9.69%	2,816 $156,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $3,100 - $4,043	63 Added 2.06%	3,118 $200,000
Q3 2019 Oct 02, 2019	BUY	$42.77 - $50.71 $42,770 - $50,710	1,000 Added 48.66%	3,055 $154,000
Q1 2019 Apr 10, 2019	SELL	$45.12 - $53.8 $13,536 - $16,140	-300 Reduced 12.74%	2,055 $0
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $19,504 - $25,292	-400 Reduced 14.52%	2,355 $122,000
Q2 2018 Jul 11, 2018	SELL	$50.53 - $62.98 $7,579 - $9,447	-150 Reduced 5.16%	2,755 $0
Q1 2018 Apr 17, 2018	SELL	$59.92 - $68.98 $171,371 - $197,282	-2,860 Reduced 49.61%	2,905 $0
Q4 2017 Jan 11, 2018	SELL	$59.94 - $65.35 $5,994 - $6,534	-100 Reduced 1.71%	5,765 $0
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $2,209 - $2,549	40 Added 0.69%	5,865 $0
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $321,714 - $371,285	5,825	5,825 $0

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.15 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.36 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.52 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account